The FANCC Gene and Its Products

  • Susan M. Gordon
  • Manuel Buchwald
Part of the Medical Intelligence Unit book series


Fanconi anaemia (FA) is an autosomal recessive disorder characterized by progressive pancytopaenia and predisposition to malignancy, often accompanied by congenital malformations. The cellular phenotype of FA includes increased chromosomal instability and accumulation in the G2 phase of the cell cycle, both of which are exacerbated by the hallmark sensitivity of FA cells to DNA crosslinking agents such as mitomycin C (MMC) and diepoxybutane (DEB). FA is genetically heterogeneous, consisting of at least eleven complementation groups, the genes for eight of which have been cloned. FANCC was the first gene causal for FA to be identified, and consequently has been the most intensively studied. Loss of function studies have demonstrated an important role for FANCC in the proliferation of germ cells and haematopoietic stem cells (HPCs). Together with the protein products of at least five other FA genes, FANCC participates in the formation of a nuclear protein complex, the formation of which is required for monoubiquitination of the FANCD2 protein. This cooperative action of the FA proteins fits well with the indistinguishable clinical presentation and universal cellular crosslinker sensitivity of the complementation groups. However, despite its ability to participate in a nuclear protein complex and possible involvement in nuclear activities such as DNA repair and transcriptional regulation, FANCC is unique among the FA proteins in having a predominandy cytoplasmic cellular localization. Investigation of possible cytoplasmic roles for FANCC have revealed it to be a multifunctional protein involved in the suppression of cell death in response to a wide range of stimuli including DNA-crosslinking agents, factor withdrawl, dsRNA, stimulatory cytokines and Fas ligation, as well as a having a possibly interrelated role in maintaining of the redox state of the cell.


Fanconi Anemia Promyelocytic Leukemia Zinc Finger Nevoid Basal Cell Carcinoma Syndrome Haematopoietic Progenitor Cell Fanconi Anaemia Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Strathdee CA, Gavish H, Shannon WR et al. Cloning of cDNAs for Fanconi’s anaemia by functional complementation. Nature 1992; 358:434.PubMedGoogle Scholar
  2. 2.
    Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2:446–57.PubMedGoogle Scholar
  3. 3.
    Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1:196–8.PubMedGoogle Scholar
  4. 4.
    Morris DJ, Reis A. A YAC contig spanning the nevoid basal cell carcinoma syndrome, Fanconi anaemia group C, and xeroderma pigmentosum group A loci on chromosome 9q. Genomics 1994; 23:23–9.PubMedGoogle Scholar
  5. 5.
    Gibson RA, Buchwald M, Roberts RG et al. Characterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCR. Hum Mol Genet 1993; 2:35–8.PubMedGoogle Scholar
  6. 6.
    Gibson RA, Hajianpour A, Murer-Orlando M et al. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet 1993; 2:797–9.PubMedGoogle Scholar
  7. 7.
    Savoia A, Centra M, Ianzano L et al. Characterization of the 5’ region of the Fanconi anaemia group C (FACC) gene. Hum Mol Genet 1995; 4:1321–6.PubMedGoogle Scholar
  8. 8.
    Tower PA, Christianson TA, Peters ST et al. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors. Exp Hematol 1998; 26:19–26.PubMedGoogle Scholar
  9. 9.
    Liebetrau W, Budde A, Savoia A et al. p53 activates Fanconi anemia group C gene expression. Hum Mol Genet 1997; 6:277–83.PubMedGoogle Scholar
  10. 10.
    Wevrick R, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet 1993; 2:655–62.PubMedGoogle Scholar
  11. 11.
    Wevrick R, Barker JE, Nadeau JH et al. Mapping of the murine and rat Facc genes and assessment of flexed-tail as a candidate mouse homolog of Fanconi anemia group C. Mamm Genome 1993; 4:440–4.PubMedGoogle Scholar
  12. 12.
    Wong JCY, Alon N, Buchwald M. Cloning of the bovine and rat Fanconi anemia group C cDNA. Mamm Genome 1997; 8:522–5.Google Scholar
  13. 13.
    Yamashita T, Kupfer GM, Naf D et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci USA 1998; 95:13085–90.PubMedGoogle Scholar
  14. 14.
    Parker L, dos Santos C, Buchwald M. The delta327 mutation in the Fanconi anemia group C gene generates a novel transcript lacking the first two coding exons. Hum Mutat 1998; Suppl:S275–7.Google Scholar
  15. 15.
    Murer-Orlando M, Llerena JC, Jr., Birjandi F et al. FACC gene mutations and early prenatal diagnosis of Fanconi’s anaemia. Lancet 1993 342:686.PubMedGoogle Scholar
  16. 16.
    Gibson RA, Morgan NV, Goldstein LH et al. Novel mutations and polymorphisms in the Fanconi anemia group C gene. Hum Mutat 1996; 8:140–8.PubMedGoogle Scholar
  17. 17.
    Whitney MA, Saito H, Jakobs PM et al. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 1993; 4:202–5.PubMedGoogle Scholar
  18. 18.
    Lo Ten Foe JR, Kruyt FA, Zweekhorst MB et al. Exon 6 skipping in the Fanconi anemia C gene associated with a nonsense/missense mutation (775C->T) in exon 5: the first example of a nonsense mutation in one exon causing skipping of another downstream. Hum Mutat 1998; Suppl:S25–7.Google Scholar
  19. 19.
    Lo Ten Foe JR, Rooimans MA, Joenje H, Arwert F. Novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia C gene, FAC. Hum Mutat 1996; 7:264–5.Google Scholar
  20. 20.
    Lo ten Foe JR, Barel MT, Thuss P et al. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant. Hum Genet 1996; 98:522–3.Google Scholar
  21. 21.
    Waisfisz Q, Morgan NV, Savino M et al. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 1999; 22:379–83.PubMedGoogle Scholar
  22. 22.
    Gavish H, dos Santos CC, Buchwald M. A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Hum Mol Genet 1993; 2:123–6.PubMedGoogle Scholar
  23. 23.
    Youssoufian H, Li Y, Martin ME et al. Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele. J Clin Invest 1996; 97:957–62.PubMedGoogle Scholar
  24. 24.
    Gibson RA, Ford D, Jansen S et al. Genetic mapping of the FACC gene and linkage analysis in Fanconi anaemia families. J Med Genet 1994; 31:868–71.PubMedGoogle Scholar
  25. 25.
    Verlander PC, Lin JD, Udono MU et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54:595–601.PubMedGoogle Scholar
  26. 26.
    Faivre L, Guardiola P, Lewis C et al. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood 2000; 96:4064–70.PubMedGoogle Scholar
  27. 27.
    Yamashita T, Wu N, Kupfer G et al. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996; 87:4424–32.PubMedGoogle Scholar
  28. 28.
    Futaki M, Yamashita T, Yagasaki H et al. The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 2000; 95:1493–8.PubMedGoogle Scholar
  29. 29.
    Seal S, Barfoot R, Jayatilake H et al. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res 2003; 63:8596–9.PubMedGoogle Scholar
  30. 30.
    Awan A, Malcolm Taylor G, Gokhale DA et al. Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia [letter]. Blood 1998; 91:4813–4.PubMedGoogle Scholar
  31. 31.
    van der Heijden MS, Yeo CJ, Hruban RH et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003; 63:2585–8.PubMedGoogle Scholar
  32. 32.
    Rischewski JR, Clausen H, Leber V et al. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy. Klin Padiatr 2000; 212:174–6.PubMedGoogle Scholar
  33. 33.
    Krasnoshtein F, Buchwald M. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients. Hum Mol Genet 1996; 5:85–93.PubMedGoogle Scholar
  34. 34.
    Brady G, Billia F, Knox J et al. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol 1995; 5:909–22.PubMedGoogle Scholar
  35. 35.
    Aube M, Lafrance M, Brodeur I et al. Fanconi anemia genes are highly expressed in primitive CD34+ hematopoietic cells. BMC Blood Disord 2003; 3:1.PubMedGoogle Scholar
  36. 36.
    Youssoufian H. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 1996; 97:2003–10.PubMedGoogle Scholar
  37. 37.
    Joenje H, Youssoufian H, Kruyt FA et al. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension. Blood Cells Mol Dis 1995; 21:182–91.PubMedGoogle Scholar
  38. 38.
    Heinrich MC, Silvey KV, Stone S et al. Posttranscriptional cell cycle-dependent regulation of hu man FANCC expression. Blood 2000; 95:3970–7.PubMedGoogle Scholar
  39. 39.
    Kupfer GM, Yamashita T, Naf D et al. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 1997; 90:1047–54.PubMedGoogle Scholar
  40. 40.
    Brodeur I, Goulet I, Tremblay CS et al. Regulation of the Fanconi anemia group C protein through proteolytic modification. J Biol Chem 2004; 279:4713–20.PubMedGoogle Scholar
  41. 41.
    Hoshino T, Wang J, Devetten MP et al. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 1998; 91:4379–86.PubMedGoogle Scholar
  42. 42.
    Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 1994; 91:7975–9.PubMedGoogle Scholar
  43. 43.
    Yamashita T, Barber DL, Zhu Y et al. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 1994; 91:6712–6.PubMedGoogle Scholar
  44. 44.
    Youssoufian H, Auerbach AD, Verlander PC et al. Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex. J Biol Chem 1995; 270:9876–82.PubMedGoogle Scholar
  45. 45.
    Hoatlin ME, Christianson TA, Keeble WW et al. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood 1998; 91:1418–25.PubMedGoogle Scholar
  46. 46.
    Savoia A, Garcia-Higuera I, D’Andrea AD. Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity [letter]. Blood 1999; 93:4025–6.PubMedGoogle Scholar
  47. 47.
    Hoatlin ME, Zhi Y, Ball H et al. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 1999; 94:3737–47.PubMedGoogle Scholar
  48. 48.
    Pace P, Johnson M, Tan WM et al. FANCE: the link between Fanconi anaemia complex assembly and activity. Embo J 2002; 21:3414–23.PubMedGoogle Scholar
  49. 49.
    de Winter JP, Leveille F, van Berkel CG et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 2000; 67:1306–8.PubMedGoogle Scholar
  50. 50.
    Medhurst AL, Huber PA, Waisfisz Q et al. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet 2001; 10:423–9.PubMedGoogle Scholar
  51. 51.
    Gordon SM, Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2-and 3-hybrid systems. Blood 2003; 102:136–41.PubMedGoogle Scholar
  52. 52.
    Taniguchi T, D’Andrea AD. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 2002; 100:2457–62.PubMedGoogle Scholar
  53. 53.
    Garcia-Higuera I, Taniguchi T, Ganesan S et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7:249–62.PubMedGoogle Scholar
  54. 54.
    Kupfer GM, Naf D, Suliman A et al. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 1997; 17:487–90.PubMedGoogle Scholar
  55. 55.
    Garcia-Higuera I, Kuang Y, Naf D et al. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19:4866–73.PubMedGoogle Scholar
  56. 56.
    de Winter JP, van der Weel L, de Groot J et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 2000; 9:2665–74.PubMedGoogle Scholar
  57. 57.
    Meetei AR, de Winter JP, Medhurst AL et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35:165–70.PubMedGoogle Scholar
  58. 58.
    Thomashevski A, High AA, Drozd M et al. The fanconi anemia core complex forms 4 different sized complexes in different subcellular compartments. J Biol Chem 2004; 13:13.Google Scholar
  59. 59.
    Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage-and cell cycle-regulated manner. J Biol Chem 2001; 276:23391–6.PubMedGoogle Scholar
  60. 60.
    McMahon LW, Sangerman J, Goodman SR et al. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 2001; 40:7025–7034.PubMedGoogle Scholar
  61. 61.
    Barna M, Merghoub T, Costoya JA et al. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell 2002; 3:499–510.PubMedGoogle Scholar
  62. 62.
    Dai MS, Chevallier N, Stone S et al. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. J Biol Chem 2002; 277:26327–34.PubMedGoogle Scholar
  63. 63.
    Kruyt FA, Dijkmans LM, Arwert F et al. Involvement of the Fanconi’s anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase. Cancer Res 1997; 57:2244–51.PubMedGoogle Scholar
  64. 64.
    Heinrich MC, Hoatlin ME, Zigler AJ et al. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood 1998; 91:275–87.PubMedGoogle Scholar
  65. 65.
    Sala-Trepat M, Rouillard D, Escarceller M et al. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res 2000; 260:208–15.PubMedGoogle Scholar
  66. 66.
    Akkari YM, Bateman RL, Reifsteck CA et al. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol Genet Metab 2001; 74:403–12.PubMedGoogle Scholar
  67. 67.
    Kupfer GM, D’Andrea AD. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood 1996; 88:1019–25.PubMedGoogle Scholar
  68. 68.
    Marathi UK, Howell SR, Ashmun RA et al. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood 1996; 88:2298–305.PubMedGoogle Scholar
  69. 69.
    Kruyt FA, Dijkmans LM, van den Berg TK et al. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 1996; 87:938–48.PubMedGoogle Scholar
  70. 70.
    Freie B, Li X, Ciccone SL, et al. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 2003; 102:4146–52.PubMedGoogle Scholar
  71. 71.
    Ridet A, Guillouf C, Duchaud E et al. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997; 57:1722–30.PubMedGoogle Scholar
  72. 72.
    Guillouf C, Vit JP, Rosselli F. Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation. Biochimie 2000; 82:51–8.PubMedGoogle Scholar
  73. 73.
    Clarke AA, Gibson FM, Scott J et al. Fanconi’s anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies. Haematologica 2004; 89:11–20.PubMedGoogle Scholar
  74. 74.
    Segal GM, Magenis RE, Brown M et al. Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 1994; 94:846–52.PubMedGoogle Scholar
  75. 75.
    Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet 1996; 12:448–51.PubMedGoogle Scholar
  76. 76.
    Whitney MA, Royle G, Low MJ et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 1996; 88:49–58.PubMedGoogle Scholar
  77. 77.
    Tomkins DJ, Care M, Carreau M et al. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model. Mutat Res 1998; 408:27–35.PubMedGoogle Scholar
  78. 78.
    Otsuki T, Wang J, Demuth I et al. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells. Int J Hematol 1998; 67:243–8.PubMedGoogle Scholar
  79. 79.
    Nadler JJ, Braun RE. Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells. Genesis 2000; 27:117–23.PubMedGoogle Scholar
  80. 80.
    Haneline LS, Broxmeyer HE, Cooper S et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/-mice. Blood 1998; 91:4092–8.PubMedGoogle Scholar
  81. 81.
    Haneline LS, Gobbett TA, Ramani R et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood 1999; 94:1–8.PubMedGoogle Scholar
  82. 82.
    Carreau M, Gan OI, Liu L et al. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced re construction ability. Exp Hematol 1999; 27:1667–74.PubMedGoogle Scholar
  83. 83.
    Aube M, Lafrance M, Charbonneau C et al. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors. Stem Cells 2002; 20:438–47.PubMedGoogle Scholar
  84. 84.
    Otsuki T, Nagakura S, Wang J et al. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice. J Cell Physiol 1999; 179:79–86.PubMedGoogle Scholar
  85. 85.
    Haneline LS, Li X, Ciccone SL et al. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/-hematopoietic stem cells and decreases the risk of clonal evolution. Blood. 2003; 101:1299–1307.PubMedGoogle Scholar
  86. 86.
    Carreau M, Gan OI, Liu L et al. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. Blood 1998; 91:2737–2744.PubMedGoogle Scholar
  87. 87.
    Gush KA, Fu KL, Grompe M et al. Phenotypic correction of Fanconi anemia group C knockout mice. Blood 2000; 95:700–4.PubMedGoogle Scholar
  88. 88.
    Cumming RC, Liu JM, Youssoufian H et al. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood. 1996; 88:4558–67.PubMedGoogle Scholar
  89. 89.
    Wang J, Otsuki T, Youssoufian H et al. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Res 1998; 58:3538–41.PubMedGoogle Scholar
  90. 90.
    Rathbun RK, Faulkner GR, Ostroski MH et al. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 1997; 90:974–985.PubMedGoogle Scholar
  91. 91.
    Koh PS, Hughes GC, Faulkner GR et al. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily. Exp Hematol 1999; 27:1–8.PubMedGoogle Scholar
  92. 92.
    Rathbun RK, Christianson TA, Faulkner GR et al. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood 2000; 96:4204–11.PubMedGoogle Scholar
  93. 93.
    Rutherford TR, Myatt NE, Gibson FM et al. The Fanconi anemia cell line HSC536N is not sensitive to interferon-gamma and does not cleave PARP in response to FAS-mediated cell killing. Blood 2002; 99:2627–8; discussion 2629—30.PubMedGoogle Scholar
  94. 94.
    Pang Q, Fagerlie S, Christianson TA et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol 2000; 20:4724–35.PubMedGoogle Scholar
  95. 95.
    Fagerlie S, Lensch MW, Pang Q et al. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells. Exp Hematol 2001; 29:1371–81.PubMedGoogle Scholar
  96. 96.
    Pang Q, Christianson TA, Keeble W et al. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood 2001; 98:1392–401.PubMedGoogle Scholar
  97. 97.
    Pang Q, Keeble W, Diaz J et al. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood 2001; 97:1644–52.PubMedGoogle Scholar
  98. 98.
    Pang Q, Keeble W, Christianson TA et al. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. Embo J 2001; 20:4478–89.PubMedGoogle Scholar
  99. 99.
    Pang Q, Christianson TA, Keeble W et al. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling path way requires the Fanconi anemia protein, FANCC. J Biol Chem 2002; 277:49638–43.PubMedGoogle Scholar
  100. 100.
    Kurre P, Anandakumar P, Grompe M et al. In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC. Exp Hematol 2002; 30:1257–62.PubMedGoogle Scholar
  101. 101.
    Escarceller M, Buchwald M, Singleton BK et al. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J Mol Biol. 1998; 279:375–85.PubMedGoogle Scholar
  102. 102.
    Lackinger D, Ruppitsch W, Ramirez MH et al. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages. FEBS Lett 1998; 440:103–6.PubMedGoogle Scholar
  103. 103.
    Pichierri P, Averbeck D, Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum Mol Genet 2002; 11:2531–46.PubMedGoogle Scholar
  104. 104.
    Digweed M, Rothe S, Demuth I et al. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 2002; 23:1121–6.PubMedGoogle Scholar
  105. 105.
    Clarke AA, Philpott NJ, Gordon-Smith EC et al. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol. 1997; 96:240–7.PubMedGoogle Scholar
  106. 106.
    Kruyt FA, Hoshino T, Liu JM et al. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 1998; 92:3050–6.PubMedGoogle Scholar
  107. 107.
    Cumming RC, Lightfoot J, Beard K et al. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001; 7:814–20.PubMedGoogle Scholar
  108. 108.
    Hadjur S, Ung K, Wadsworth L et al. Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. Blood 2001; 98:1003–11.PubMedGoogle Scholar
  109. 109.
    Pearl-Yafe M, Halperin D, Halevy A et al. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells. Biochem Pharmacol. 2003; 65:833–42.PubMedGoogle Scholar
  110. 110.
    Pearl-Yafe M, Halperin D, Scheuerman O et al. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol 2004; 67:539–46.PubMedGoogle Scholar
  111. 111.
    Hadjur S, Jirik FR. Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. Blood 2003; 101:3877–84PubMedGoogle Scholar
  112. 112.
    Saadatzadeh MR, Bijangi-Vishehsaraei K, Hong P et al. Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway. J Biol Chem 2004; 279:16805–12.PubMedGoogle Scholar
  113. 113.
    Takeda K, Matsuzawa A, Nishitoh H et al. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003; 28:23–9.PubMedGoogle Scholar
  114. 114.
    Cuddihy AR, Wong AH, Tarn NW et al. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 1999; 18:2690–702.PubMedGoogle Scholar
  115. 115.
    Cho SG, Lee YH, Park HS et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 2001; 276:12749–55.PubMedGoogle Scholar
  116. 116.
    Gilot D, Loyer P, Corlu A, et al. Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J Biol Chem 2002; 277:49220–9.PubMedGoogle Scholar
  117. 117.
    Barber LM, McGrath HE, Meyer S, et al. Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia. Br J Haematol 2003; 121:57–62.PubMedGoogle Scholar

Copyright information

© and Springer Science+Business Media 2006

Authors and Affiliations

  • Susan M. Gordon
    • 1
  • Manuel Buchwald
    • 2
  1. 1.Program in Genetics and Genomic Biology, Research InstituteHospital for Sick ChildrenTorontoCanada
  2. 2.Department of Molecular and Medical GeneticsUniversity of TorontoTorontoCanada

Personalised recommendations